Furthermore, in a in vivo study using a prostate cancer mouse model, mice that were treated with an EP1 antagonist showed a significantly lower incidence of cancer at simultaneously a higher percentage of apoptotic cells compared to control (Masato et. The gene discussed is PTGER1; the disease is cancer.